The U.S. Food and Drug Administration has approved Indianapolis-based Eli Lilly's new treatment for moderate to severe eczema ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

Although Lilly started consistently raising its dividend in 2015, investors should be aware of some details around the schedule of these payments. Every year since then, Lilly announced a hike to its ...

The likely unification of Ireland will mean a greater economic role for the west but we need to plan for development like the ...

The investments are part of Lilly's ongoing commitment to expand production for its top-selling diabetes and obesity drugs ...

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 586.36% and ...

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

SOMAÍ Pharmaceuticals partners with Georgelle to offer Irish patients a broad range of cannabis-based medicines, expanding ...

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

Groundbreaking for the Limerick site took place in March 2023, with production expected to commence in 2026. The September 13, 2024 announcement of the additional investment signifies Eli Lilly's ...